BioCentury
ARTICLE | Company News

Aventis SA, Sanofi-Synthelabo SA deal

August 23, 2004 7:00 AM UTC

SAN completed its previously announced acquisition of AVE for E37.6 million in stock and E16.1 million in cash, or a total of E53.8 million ($66.5 million). The company changed its name to Sanofi-Aven...